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Abstract
Background: There is uncertainty about how GPs should convey information about treatment
effectiveness to their patients in the context of cardiovascular disease. Hence we study the
concordance of decisions based on one of four single information formats for treatment
effectiveness with subsequent decisions based on all four formats combined with a pictorial
representation.
Methods: A randomized study comprising 1,169 subjects aged 40–59 in Odense, Denmark.
Subjects were randomized to receive information in terms of absolute risk reduction (ARR),
relative risk reduction (RRR), number needed to treat (NNT), or prolongation of life (POL)
without heart attack, and were asked whether they would consent to treatment. Subsequently the
same information was conveyed with all four formats jointly accompanied by a pictorial
presentation of treatment effectiveness. Again, subjects should consider consent to treatment.
Results: After being informed about all four formats, 52%–79% of the respondents consented to
treatment, depending on level of effectiveness and initial information format. Overall, ARR gave
highest concordance, 94% (95% confidence interval (91%; 97%)) between initial and final decision,
but ARR was not statistically superior to the other formats.
Conclusion: Decisions based on ARR had the best concordance with decisions based on all four
formats and pictorial representation, but the difference in concordance between the four formats
was small, and it is unclear whether respondents fully understood the information they received.
Background
Chronic disease processes (e.g. atherosclerosis, osteoporo-
sis, carcinogenesis) account for 80–85% of all mortality in
Norway and the UK (Statistics Norway, Statistics UK), and
probably most industrialised countries. A considerable
proportion of GPs' time is devoted to the detection and
interventions related to such processes through case-find-
ing, screening, life-style changes, pharmaceuticals or other
medical interventions. In shared decision making GPs are
supposed to inform patients about the effectiveness of
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challenge to busy doctors who do not have the time to
provide patients with comprehensive information about
effectiveness of therapies. In practice, they may choose to
provide brief information, and the question is how this is
best done. While clinical trials quantify the health conse-
quences of the interventions under ideal, controlled con-
ditions, the effect is often diluted in realistic, non-
controlled settings, where studies have found that only
few interventions yield more than 12 months in addi-
tional average life time [2]. One likely explanation is that
neither patients nor doctors experience any immediate
effects, except for potential side effects, and therefore
patients may lose the motivation for adhering to the treat-
ment. This is frequently the case for statins and bisphos-
phonates [3], where interventions often are discontinued
after 1–2 years. In part, this suboptimal adherence may be
a consequence of the patient not feeling sufficiently well-
informed about the potential benefits of adhering to treat-
ment [4].
The standard, single formats of intervention effectiveness
are: absolute risk reduction (ARR), relative risk reduction
(RRR) and number needed to treat (NNT). In contrast to
these formats that are measured at a specific point in time,
prolongation of (disease-free) life (POL) has been sug-
gested as a measure that summarises gain over the entire
time scale. This has also been termed postponement of
adverse outcomes [4]. None of these formats as such
inform patients about their baseline risk, i.e. for example
the heart attack risk during the subsequent 10 years.
Little is known about which single format, information
should have to achieve decisions that most closely reflect
the decision made when the patient has received compre-
hensive and nuanced information, and therefore at least
in theory is in a better position to make qualified deci-
sions. While others have shown that decisions can be
manipulated by framing the information in a particular
format [5], we are not aware of any studies that have
focused on identifying which single format(s) that leads
to decisions that would be upheld when given compre-
hensive information.
A further issue is the way in which each format is pre-
sented. ARR and RRR can be presented in terms of percent-
ages, relative frequencies and pictorial representation.
NNT can also be presented in different ways [5], and POL
can be presented with or without information about the
distribution around the mean value. While it is known
that different presentations of essentially the same infor-
mation influence consent rates [5,4,6], less is known
about how this influences patients' ability to reach a deci-
sion they will maintain when given comprehensive infor-
mation. As natural frequencies generally seem to be better
understood than mere risk estimates [7], we included a
pictorial representation of the expected treatment gain in
the final, comprehensive information that respondents
were presented with.
A priori, it would seem questionable that any one single
format could capture the full range of interpretations of
outcome data, as each format to some degree represents
different aspects of the "truth". Estimates of prolongation
of life without adverse events, whether they stem from
clinical trials or simulation models, are estimates of the
average or expected postponement of the adverse event. In
practice, it is impossible to infer the size of the prolonga-
tion for the individual patient because small prolonga-
tions in most or all patients may create the same survival
curves as large prolongations in a few. In other words, we
can infer the average health gain, but not its distribution
among those having therapy. It is therefore impossible to
determine whether the effect is "small for all" or a few are
winning "the big prize" from empirical data [8]. Although
ARR and average prolongation are generated from the
same data, the two formats "invite" the decision maker to
interpret them differently: ARR signals that a big prize
(health benefit) is won by the few, while average prolon-
gation signals smaller gain for all. Whatever the true dis-
tribution would be in a given situation, it is important to
investigate which single format leads to the same deci-
sions as those based on comprehensive information.
The aim of this study was to explore which single format
results in decisions that are closest to decisions made by
the same individual when given comprehensive informa-
tion. It is important to emphasize that comprehensive
information is not equivalent of unbiased, perfect infor-
mation – it is in this context a collective presentation of
the various formats (ARR, NNT, RRR and POL) including
a pictorial representation. If decisions made on the basis
of one single, specific interpretation of the data, i.e. one
format, differ significantly from the decisions made when
the more nuanced story is told, this will indicate that this
single format cannot necessarily replace comprehensive
information. Because it is difficult to obtain a sufficiently
large number of patients for such a study in a clinical set-
ting, we carried out a randomized study with interviews of
a representative sample of the general population.
Methods
In the autumn of 2005, a representative sample of individ-
uals aged 40–59 in the municipality of Odense, Denmark,
(approximately 185,000 inhabitants) was invited for an
interview. Interviews took place in a university building
next to the main hospital just outside the city centre. The
individuals were informed that interviews would be about
preventive healthcare and would take about 10–15 min-
utes. For their efforts, the respondents would receivePage 2 of 9
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In total, 4,000 individuals were randomly selected among
people aged 40–59 in Odense as of January 1, 2005, and
1,491 (37%) were successfully interviewed. Interviews
took place during four-hour sessions in the afternoon over
a period of six weeks. Non-responders were followed up
with reminders by letter and telephone. All interviews
were performed by professional and trained interviewers
from The Danish National Centre for Social Research.
The design of the interview guides were the result of
lengthy discussions within the research group, three dif-
ferent focus groups, and ultimately with researchers from
the The Danish National Centre for Social Research that
performed the interviews. In this paper, we present results
for 16 of the 24 interview guides. Here, the respondents
were first asked about age, gender, marital status, family
income, educational attainment and occupation. Subse-
quently, they were asked to imagine that they were at an
increased risk of a heart attack and offered a pharmaceuti-
cal drug. No drug name was mentioned, but data on effec-
tiveness and side effects resemble the outcomes associated
with statins. The respondent then received information
on treatment effectiveness in terms of one single informa-
tion format, and subsequently in terms of a picture in
combination with data on NNT, RRR and life extension
(POL) (Appendix1 [see Additional file 1]). After each
round of information, the respondents were asked
whether they would consent to therapy (yes, no, uncer-
tain) and further to indicate the strength of their consent
on a scale from 1 (="not at all") to 10 (="to a very high
degree"). Then, respondents were asked which one of the
four information formats they liked most, how difficult it
was to understand this preferred format, whether they or
their closest relative had hypercholesterolaemia, hyper-
tension, or had had a heart attack or stroke. At the end
they were asked four questions that capture numeracy
(one taken from an existing questionnaire [9,10], and
three questions made by the authors). All information
was read to the respondents while they simultaneously
could read the information on cards (cf. Appendix 2,
where the cards associated with the single information
ARR is presented as an example. Other formats had the
initial information replaced by the appropriate format
present on the card with comprehensive information [see
Additional file 2]). When the interview was finished, the
interviewers rated their perception of the respondents'
understanding of card 3 (the "comprehensive informa-
tion"). This rating was based on the interviewer's subjec-
tive impression of understanding. The full interview guide
is presented in Appendix 3 [see Additional file 3].
We aimed to test concordance for different levels of base-
line risk and effectiveness in order to explore whether the
results were specific for specific levels of risk or effective-
ness. We used 5% and 15% 10-year risk of a fatal heart
attack because these are realistic levels for situations
where the GP would consider pharmaceutical treatment.
We used 33% for RRR because this is a usual level for sta-
tin treatment, while we also assigned RRR of 40%, 66%
and 80% (Table 1). These additional RRR levels were cho-
sen to fit the study aims of formats 17–24.
Consequently, we had 4 different risk level and effective-
ness groups. Combined with baseline risks, correspond-
ing effect estimates could be derived for the three other
risk formats (derivations not shown, but available upon
request). For each set of baseline risk and effect size, either
ARR, RRR, NNT or POL was used as the initial single infor-
mation piece and thus 16 different interview formats were
used (Table 1). Additionally, we had eight other interview
guides with discrete choice questions that are not
included in the present analysis.
Because there were 24 different interview guides, each
with a unique set of information cards, we chose to let
each interviewer have one interview guide with the associ-
ated cards during each interview session (afternoon). This
was first to avoid mismatch between the format registered
for each respondent, the cards and the interview guides,
and second to keep the number of printed guides and for-
mat at a reasonable level. No single interviewer did more
than 37 interviews with any given guide of the 16 availa-
ble, and all guides had at least 5 interviewers associated
Table 1: Study design: The 16 interview formats according to baseline risk of heart attack, level of effectiveness, and initial piece of 
information
ARR RRR NNT POL
Baseline Risk Level of effectiveness Effect size n Effect size n Effect size n Effect size n
Low (5%) Low 2% 79 40% 79 50 68 4 mths 69
High 4% 75 80% 69 25 69 8 mths 67
High (15%) Low 5% 71 33% 73 20 82 8 mths 86
High 10% 69 66% 71 10 69 16 mths 73
Total 294 292 288 295Page 3 of 9
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guides according to the sequence of attending: The
sequence of the guides was random. Even though this
design does not represent perfect randomisation, we con-
sidered it to represent the best trade-off between random-
ness, feasibility and avoidance of mismatch between
registered and actual interview format.
The study was powered to detect a 15% difference in pro-
portion consent between two guides. We consequently
aimed to have 100 respondents for each interview guide,
in total 2,400 interviews.
Statistics
The basic response variable was consent to treatment after
the initial and final information, measured both on a
binary and a 10-point Likert scale. From the binary
responses we computed concordance as an indicator of
whether or not the initial choice was upheld in the final
decision. From the Likert scale responses we computed the
difference between final and initial score, i.e. a negative dif-
ference indicates that the subject became less willing to
accept treatment. As explanatory variables we used the type
of initial format (ARR, RRR, NNT, POL), level of baseline
risk (high, low), size of treatment effectiveness (high, low),
age (40–44 yrs, 45–49 yrs, 50–54 yrs, 55–60 yrs), gender,
cohabitant or not, less than two correct responses to the
four numeracy questions (yes, no), personal experience
with cardiovascular disease (yes, no), experience with cardi-
ovascular disease in family (yes, no), and the interviewer's
assessment of whether the informant seemed to under-
stand the presented information (yes, no).
To account for non-response to individual items, we
employed multiple imputation using the so-called ice and
micombine procedures available in Stata 9.2 [11,12]. In the
imputation step we used all available information for all
variables described above to generate the ten completed
datasets. Subsequently the data were analysed using either
logistic regression for binary responses (consent and con-
cordance: yes/no), or ordinary linear regression for Likert
scale outcomes (rated preference and difference in rated
preference). For the latter outcomes we used robust vari-
ance estimates to account for departures from normality
[13,14]. For all estimates we report 95% confidence inter-
vals in parentheses.
Results
Table 1 shows the design of the experiment and the
number of respondents in each of the sixteen groups.
While the overall participation rate was low (n = 1491,
37.3%), the randomisation was successful in creating
groups of equal size and composition. Compared to the
background population, the participants were older
(median age 51 among participants, 49 among non-par-
ticipants) and a higher proportion were women (57.1%
among participants, 45.2% among non-participants). Fur-
ther, the participants had a lower mean annual household
income of DKK 507 k, where the average for 40 to 49 year-
olds was DKK 639 k and for 50–59 year-olds DKK 600 k
in the general Danish population. Finally, participants
had a longer education than the general population in this
age group: Only 11% had a shorter education than 9 years
among participants, whereas this is 28% in the general
population. Furthermore, 24% of participants had an
education longer than 18 years, whereas this was the case
for 7% in the general Danish population in this age group.
From now on we only report on the 1169 subjects ran-
domised into the 16 groups relevant for this study.
Table 2 shows the characteristics of the informants accord-
ing to the initial type of information they were presented
Table 2: Descriptive statistics of the respondents according to interview format
ARR RRR NNT POL
Covariate n p/median n p/median n p/median n p/median
Sex (Females, %) 294 56.5 292 54.8 288 53.5 295 61.0
Age (years) 294 52 (43; 59) 288 51 (43;59) 288 51 (42;59) 295 51 (42; 59)
Household income (1,000 DKK) 292 500–599 (100–199; 
900–999)
289 500–599 (100–199; 
800–899)
281 500–599 (200–299; 
1,000+)
293 500–599 (200–299; 
800–899)
Education (years) 294 13 (10; 17) 292 13 (9; 16) 285 13 (10; 16) 290 12 (9; 17)
Married or cohabitating w/
partner (Yes, %)
294 73.8 292 74.0 287 81.2 293 78.5
Personal experience w/
cardiovascular disease (Yes, %)
292 39.4 290 36.2 287 33.1 295 38.3
Family w/known cardiovascular 
disease (Yes, %)
287 41.1 281 36.3 286 42.3 288 45.5
Numeracy skills (2 or more 
wrong answers, %)
294 19.7 292 18.2 288 24.0 295 17.6
For proportions, percentages are given, while for continuous and categorical variables the median is given with 10% and 90% percentiles in 
parentheses. n indicates the number of valid responsesPage 4 of 9
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groups, the randomisation seems to have been successful
in creating groups with similar characteristics among
respondents. Response rates for individual items among
respondents were generally very high.
In Table 3 we present proportions of respondents willing
to accept treatment after the initial and final information,
and the corresponding concordances, stratified by format,
level of baseline risk, and level of effectiveness. Concord-
ance is finally displayed stratified according to initial con-
sent status with respect to therapy. Similarly, in Table 4 we
present the average scores on the Likert scale after initial
and final information, as well as the average of individual
differences. In general, the proportion of informants
accepting treatment was about 70% regardless of initially
presented outcome format. In fact, across all formats and
both rounds of questions, the lowest proportion was 53%
and the highest 78% (Table 3). The subjects were some-
what sensitive to the level of effectiveness in terms of their
willingness to accept treatment, be it binary or on the Lik-
ert scale, but the picture was not entirely consistent. An
entirely consistent pattern would imply that the propor-
tions consenting to therapy increased monotonously with
increasing effectiveness, and that was not the case (see
Table 3). This pattern was repeated for concordance, but
not for individual differences on the Likert scale, where
the level of effectiveness seemed to play a less important
role. The format resulting in the highest concordance was
ARR, followed by RRR, POL, and NNT, in that order, but
differences were small. The smallest average difference
was achieved with the ARR and NNT formats jointly, fol-
lowed by RRR and POL, in that order. Again the differ-
Table 3: Preferences for therapy: proportions of respondents consenting to the proposed therapy with binary response (yes/no)
Proportions (%) consenting to initial proposal
Baseline Risk Level of effectiveness ARR RRR NNT POL
Low Small 60 (48; 70) 65 (53; 75) 56 (43; 68) 49 (37; 61)
Large 71 (59; 80) 78 (65; 87) 67 (54; 77) 59 (47; 70)
High Small 72 (60; 81) 77 (65; 85) 70 (59; 80) 53 (43, 64)
Large 67 (55; 77) 73 (61; 82) 73 (61; 83) 64 (53; 74)
Total 67 (61; 72) 73 (67; 78) 67 (61; 72) 56 (51; 62)
Proportions (%) consenting to final proposal
Baseline Risk Level of effectiveness ARR RRR NNT POL
Low Small 59 (48; 70) 57 (46; 68) 52 (40; 64) 60 (47; 71)
Big 71 (59; 80) 71 (59; 81) 64 (51; 74) 66 (54; 76)
High Small 70 (58; 80) 69 (57; 79) 71 (60; 80) 60 (49; 70)
Big 67 (55; 77) 73 (61; 82) 79 (68; 87) 71 (60; 80)
Total 67 (61; 72) 67 (62; 73) 67 (61; 72) 64 (58; 69)
Concordance (%) between initial and final response
Baseline Risk Level of effectiveness ARR RRR NNT POL
Low Small 90 (81; 95) 93 (83; 97) 84 (72; 91) 86 (76; 93)
Big 100 (94; 100) 91 (80; 96) 91 (81; 96) 93 (83; 97)
High Small 92 (82; 97) 88 (78; 94) 91 (82; 96) 90 (81; 95)
Big 97 (89; 99) 94 (85; 98) 90 (79; 95) 93 (85; 97)
Total 94 (91; 97) 91 (87; 94) 89 (84; 92) 90 (86; 93)
Concordance (%) between initial and final response according to initial response
Initial consent? ARR RRR NNT POL
No 92 (84; 96) 94 (84; 98) 83 (74; 90) 80 (72; 86)
Yes 95 (91; 98) 90 (84; 94) 92 (86; 95) 98 (94; 100)Page 5 of 9
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were small.
The last sub-tables of Table 3 and 4 do, however, reveal an
additional pattern. Informants were generally most con-
cordant when they initially accepted treatment, but with
substantial differences between formats: For RRR, con-
cordance was highest among those who initially declined
treatment ("too many" consented to treatment initially
compared to their final choice), for POL this is reversed
("too many" declined treatment initially compared to
their final choice). For NNT, concordance was low regard-
less of the initial decision, while it was high for ARR, again
regardless of initial choice.
In regression analyses of concordance and difference on
Likert scales (Table 5) no statistically significant interac-
tions between initial format and the other covariates were
found. Most effects were small and not statistically signif-
icant, except for the association between level of effective-
ness and concordance. None of the explanatory variables
changed substantially when adjusted for the remaining
covariates, i.e. we could not identify any important factors
that could have confounded the overall results. This
includes individuals' disease history, which only affected
the overall tendency to consent to treatment, but not con-
cordance. Hence, the format leading to the most concord-
ant decisions according to the adjusted logistic regression
was again the ARR followed by RRR, POL, and NNT. For
the average difference on the Likert scale, the adjusted lin-
Table 4: Preferences for therapy according to interview format, Likert scale response
Initial agreement to receive treatment on Likert scale
Baseline risk Level of effectiveness ARR RRR NNT POL
Low Small 7.29 (6.65; 7.93) 6.16 (5.40; 6.91) 5.29 (4.44; 6.15) 5.39 (4.70; 6.08)
Large 7.03 (6.31; 7.76) 6.64 (5.93; 7.34) 6.70 (5.94; 7.45) 6.13 (5.39; 6.88)
High Small 6.03 (5.25; 6.81) 6.73 (6.05; 7.42) 6.63 (6.00; 7.26) 5.48 (4.82; 6.13)
Large 6.36 (5.57; 7.15) 6.87 (6.18; 7.57) 6.87 (6.13; 7.61) 6.68 (5.97; 7.40)
Total 6.70 (6.33; 7.07) 6.59 (6.23; 6.95) 6.39 (6.01; 6.77) 5.91 (5.55; 6.26)
Final agreement to receive treatment on Likert scale
Baseline risk Level of effectiveness ARR RRR NNT POL
Low Small 6.97 (6.29; 7.66) 5.54 (4.75; 6.32) 5.00 (4.15; 5.86) 5.99 (5.26; 6.71)
Large 6.88 (6.13; 7.63) 6.42 (5.68; 7.16) 6.55 (5.79; 7.31) 6.66 (5.92; 7.39)
High Small 6.07 (5.32; 6.82) 6.29 (5.53; 7.05) 6.67 (6.03; 7.32) 5.94 (5.26; 6.62)
Large 6.22 (5.44; 7.01) 6.54 (5.86; 7.21) 6.64 (5.92; 7.35) 6.86 (6.17; 7.56)
Total 6.56 (6.18; 6.93) 6.18 (5.80; 6.55) 6.24 (5.86; 6.62) 6.34 (5.99; 6.70)
Difference between initial and final agreement to receive treatment on Likert scale
Baseline risk Level of effectiveness ARR RRR NNT POL
Low Small -0.32 (-0.70; 0.07) -0.62 (-0.98; -0.26) -0.29 (-0.79; 0.21) 0.59 (0.15; 1.04)
Large -0.16 (-0.48; 0.17) -0.22 (-0.60; 0.17) -0.15 (-0.50; 0.21) 0.52 (0.18; 0.87)
High Small 0.04 (-0.19; 0.28) -0.45 (-0.86; -0.03) 0.04 (-0.37; 0.44) 0.47 (0.04; 0.89)
Large -0.14 (-0.36; 0.08) -0.34 (-0.70; 0.02) -0.23 (-0.72; 0.26) 0.18 (-0.08; 0.44)
Total -0.15 (-0.30; 0.01) -0.41 (-0.60; -0.22) -0.15 (-0.37; 0.07) 0.44 (0.25; 0.63)
Difference between initial and final agreement to receive treatment on Likert scale with respect to 
initial choice
Initial treatment 
acceptance
ARR RRR NNT POL
No 0.10 (-0.12; 0.32) 0.03 (-0.28; 0.33) 0.52 (0.17; 0.87) 0.97 (0.64; 1.31)
Yes -0.27 (-0.47; -0.07) -0.58 (-0.82; -0.33) -0.48 (-0.75; -0.21) 0.02 (-0.18; 0.22)Page 6 of 9
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as ARR followed by NNT, RRR, and POL.
Discussion
Of the four formats used for initial information (ARR,
RRR, NNT, POL), the ARR format led to the "best" deci-
sion in the sense that the decisions were upheld to a
greater extent with ARR than for the other formats, but
ARR was not statistically superior to the other formats.
The subjects were given incentives to improve participa-
tion rates, but it remained low at 37.3%. Further, partici-
pation rates were related to gender, age, and socio-
economic status. While this may question the generalisa-
bility of the study, the internal validity would appear to be
intact, as the randomisation was successful in creating
equal sized and comparable groups, and as there were no
drop-outs after randomisation. To further avoid drop-outs
occurring as a side effect of incomplete responses – often
only complete cases are included in statistical analyses –
we employed the technique of multiple imputation to
make use of all available information. Additional regres-
sion analyses without multiple imputations and conse-
quently fewer respondents yield similar results, but with
less precision (data not shown).
Although the study was intended to mimic a "real" treat-
ment decision as much as possible, the study did depart
from this ideal in that participants were not patients. We
hence controlled for personal and/or familial experience
of disease in analyses. While experience with disease did
increase overall willingness to consent to therapy, it did
not affect concordance significantly. In terms of identify-
ing the "best" format, i.e. the one with highest concord-
ance, our results can thus reasonably be expected to
translate well into a clinical setting.
Participants were presented with rather large variations in
the levels of treatment effectiveness, and yet the propor-
tions of consent to therapy varied little. One may hypoth-
esize two explanations for this insensitivity: (i)
respondents do not understand the information they
receive; (ii) respondents understand the information, but
make decision on factors other than effectiveness. Several
studies have shown that lay people are insensitive to levels
of effectiveness in hypothetical treatment decision when
the effectiveness is presented in terms of NNT [15-17]. The
explanation may be evaluability heuristics created by the
fact that lay people have little or no experience with eval-
uating NNTs. Without experience in evaluating effective-
ness information, people may make decisions on the basis
of factors that they understand or that create affect15.
While levels of effectiveness do not seem to influence
decisions when presented in terms of NNT, the cost of the
treatment, the type of side effects and the type of disease
have considerable influence in similar experiments [16].
Such aspects may be much easier to evaluate. While previ-
ous research indicates that NNT and RRR may be subject
to evaluability heuristics, POL seems to be less so. In two
experiments, lay people have been able to discriminate
between levels of effectiveness when presented with a pro-
longation of life without adverse events [4,18]. Interest-
ingly, even respondents who were presented with POL,
were relatively insensitive to levels of effectiveness in the
present study.
The relative insensitivity to level of effectiveness will tend
to hide the influence of information format because most
consent rates were in the range 60%–75%. The concord-
ance proportions were generally high and this limited the
scope for differences between formats. While this raises
the question of the study not being sufficiently sensitive to
detect differences in concordance proportions, it more
Table 5: Association between concordance or difference of initial and final treatment acceptance and format initially presented. All 
estimates are based on multiple imputation.
Concordance Difference
OR (Crude) OR (Adjusted*) Beta (Crude) Beta (Adjusted*)
Initial format ARR 1 1 (Ref) (Ref)
RRR 0.64 (0.33; 1.25) 0.62 (0.31; 1.24) -0.41 (-0.60; -0.22) -0.29 (-0.57; -0.02)
NNT 0.48 (0.25; 0.92) 0.45 (0.23; 0.87) -0.15 (-0.34; 0.04) 0.01 (-0.28; 0.29)
Delay 0.57 (0.29; 1.11) 0.52 (0.26; 1.03) 0.44 (0.25; 0.63) 0.56 (0.28; 0.84)
Base line risk Low 1 1 (Ref) (Ref)
High 1.10 (0.71; 1.71) 1.07 (0.68; 1.67) 0.06 (-0.14; 0.25) 0.03 (-0.16; 0.23)
Effect size Low 1 1 (Ref) (Ref)
High 1.74 (1.12; 2.71) 1.76 (1.12; 2.77) -0.00 (-0.20; 0.19) 0.01 (-0.19; 0.21)
* Adjustment was made for age, gender, living with a partner, numeracy, personal experience with cardiovascular disease, experience with 
cardiovascular disease in the family, and interviewer's assessment of whether the informant understood the information given.Page 7 of 9
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not subjects are capable of meaningful risk assessment
and evaluation of the true benefit associated with a given
treatment.
Even so, we did find significant differences between for-
mats, in particular we identified clear directions of
changes for two formats. Subjects initially presented with
RRR generally became less likely to consent to treatment
after receiving comprehensive information, while subjects
initially presented with POL became more willing to
accept treatment after having been given the fuller picture.
These movements were most visible on the more sensitive
Likert scale, than on the binary scale (yes/no). RRR has
previously been reported to convey an overly optimistic
impression on treatment efficacy [19] and the present
observations support this in the sense that subjects ini-
tially given RRR information tend to adjust consent to
treatment downwards when given information in other
formats. For those initially presented with NNT informa-
tion, the movements were rather large and bidirectional.
The difference was +0.52 on the Likert scale for those who
initially rejected the therapy while it was -0.48 for those
who initially accepted it. The results may possibly reflect a
lack of understanding of the NNT format as indicated in
previous studies [18,15]. Only for ARR, changes in deci-
sion were infrequent and bidirectional. This may indicate
that ARR accompanied by baseline risk information is
closest to the pictorial representation of natural frequen-
cies.
In the present study we use comprehensive information as
a common benchmark for valuing the performance of the
single formats. We argue that to the extent that single for-
mats and comprehensive information produce the same
results, one can reduce GP time and effort by providing
patients with the single information format which con-
cords best with comprehensive information. In drawing
this conclusion, we do not infer that either of the two for-
mats necessarily lead to optimal decisions. Information
can only lead to optimal decision making if individuals
understand and use all provided information in order to
optimize their individual utility function. Clearly, we can-
not verify whether this is the case. One may, however,
argue that the comprehensive information respondents
are provided with in the present study with a high proba-
bility should lead to more informed and thus better deci-
sions than decisions made on the basis of single formats
– because comprehensive information provides the
patient with a nuanced and relevant array of information.
As we have emphasized earlier, comprehensive informa-
tion presents information on effectiveness in different for-
mats, which reflect various possible distributions of
outcomes – whereas the single format implies a single dis-
tribution, which is not necessarily the true distribution.
Comprehensive information also includes pictorial repre-
sentation of natural frequencies, which has been shown to
be readily understood by many. Finally, comprehensive
information in this study includes an explicit presentation
of information on RRR. While one can argue that focus on
RRR may bias decisions and lead individuals away from
the relevant outcome (the gain in life-expectancy), it is a
fact that RRR is a piece of information that is available as
long as we provide patient with information on base-line
risk and risk reduction. What our results have shown is
that individuals presented with ARR and comprehensive
information (including an explicit presentation of RRR)
demonstrate high concordance which suggests that
explicit presentation of RRR does not have a marked
impact when this information is provided along with
information on effectiveness.
To the best of our knowledge, no similar study has previ-
ously been performed. Some aspects of the study, how-
ever, have been elucidated in previous studies. Several
studies have compared the consent rates for equal effec-
tiveness with information formats [17,4]. Typically,
respondents are more positive towards treatment when
presented with RRR than with ARR, NNT or POL. Our
results confirm this although we found relatively small
differences across the four formats. The explanation may
be that all respondents were informed about baseline risk
which would tend to put RRR in perspective. Another
explanation may be that the respondents suffered infor-
mation overload and decided on the basis of factors other
than effectiveness. Since the price of the treatment and the
side effects were identical in the 16 interview formats, the
consent rate may be relatively similar if respondents make
decisions on the basis of such factors as price or side
effects.
Because this is the first study to test the influence of four
information formats and four effectiveness levels in the
same study, one should interpret the results cautiously.
The findings may suggest that RRR and POL can be used
to manipulate decision makers because decisions made
on one single of these formats seem to produce "optimis-
tic" or "pessimistic" decisions. On the other hand it is not
clear whether lay people who are informed about NNT or
ARR make good decisions, nor is it clear whether effective-
ness is a crucial issue for people who make treatment deci-
sions. It is conceivable that people consider the severity of
the potential disease, the treatment costs and side effects
and put less emphasis on the magnitude of the effect as far
as it is above some threshold which may be close to zero
for some people.
The findings of this study and several others suggest that
people make decisions not only on the basis of health out-
come, but also on the basis of other factors such as price,Page 8 of 9
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need just as much knowledge about how patients value
health and non-health outcomes as about how to convey
information about probabilities and effect sizes.
Conclusion
While we conclude that ARR may represent the best single
information format, the study raises questions about lay
people's understanding even when special efforts are
made to convey information in an understandable way.
The study may also indicate that level of effectiveness is
not a crucial issue when making a decision about preven-
tive interventions.
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